Lars Valeur Køber

Lars Valeur Køber

Clinical Professor

Member of:

  • Internal medicine: Cardiology


Publication year:
All
1 - 8 out of 8Page size: 10
  1. 2000
  2. Published

    Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group

    Latini, R., Tognoni, G., Maggioni, A. P., Baigent, C., Braunwald, E., Chen, Z. M., Collins, R., Flather, M., Franzosi, M. G., Kjekshus, J., Køber, L., Liu, L. S., Peto, R., Pfeffer, M., Pizzetti, F., Santoro, E., Sleight, P., Swedberg, K., Tavazzi, L., Wang, W. & 1 others, Yusuf, S., 2000, In: Journal of the American College of Cardiology. 35, 7, p. 1801-7 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Dofetilid til patienter med hjerteinsufficiens og dårligt fungerende venstre ventrikel

    Torp-Pedersen, C. T., Møller, M., Bloch-Thomsen, P. E., Køber, Lars Valeur, Sandøe, E., Egstrup, K., Agner, E., Carlsen, J. E. & Videbaek, J., 2000, In: Ugeskrift for læger. 162, 44, p. 5948-53 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Dofetilide for the treatment of atrial fibrillation in patients with congestive heart failure

    Torp-Pedersen, Christian, Moller, M., Køber, Lars Valeur & Camm, A. J., 2000, In: European Heart Journal. 21, 15, p. 1204-6 2 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

    Torp-Pedersen, Christian, Brendorp, B. & Køber, Lars Valeur, 2000, In: Expert Opinion on Investigational Drugs. 9, 11, p. 2695-704 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial

    Køber, Lars Valeur, Bloch Thomsen, P. E., Møller, M., Torp-Pedersen, Christian, Carlsen, Jørn, Sandøe, E., Egstrup, K., Agner, E., Videbaek, J., Marchant, B., Camm, A. J. & Danish Investigations of Arrhythmia and Mortality on Dofetilide (DIAMOND) Study Group, D. I. O. A. A. M. O. D. (. S. G., 2000, In: Lancet. 356, 9247, p. 2052-8 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

    Flather, M. D., Yusuf, S., Køber, Lars Valeur, Pfeffer, M., Hall, A., Murray, G., Torp-Pedersen, Christian, Ball, S., Pogue, J., Moyé, L. & Braunwald, E., 2000, In: Lancet. 355, 9215, p. 1575-81 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group

    Gustafsson, I., Hildebrandt, P., Seibaek, M., Melchior, T., Torp-Pedersen, Christian, Køber, Lars Valeur & Kaiser-Nielsen, P., 2000, In: European Heart Journal. 21, 23, p. 1937-43 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Prolongation of life with angiotensin converting enzyme inhibitor therapy

    Torp-Pedersen, Christian & Køber, Lars Valeur, 2000, In: European Heart Journal. 21, 8, p. 597-8 1 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 543423